Carbetocin

Drug Profile

Carbetocin

Alternative Names: Duratobal; Duratocin; Lonactene; Pabal

Latest Information Update: 06 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Oxytocics; Posterior pituitary hormones
  • Mechanism of Action Oxytocin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Labour disorders

Most Recent Events

  • 08 Apr 2015 A new room-temperature formulation of carbetocin receives approval through the EU Mutual Recognition Procedure
  • 01 Feb 2015 Ferring initiates enrolment in a phase III trial for Labour disorders in United Kingdom (NCT02216383)
  • 10 Oct 2014 Ferring Pharmaceuticals plans a phase III trial for Labour disorders in United Kingdom (IM) (NCT02216383)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top